Research in Family Planning

Section 1: Natural Family Planning, the Fertile Period and Lactation.- 1 The reliability of women's subjective assessment of the fertile period relative to urinary gonadotrophins and follicular ultrasonic measurements during the menstrual cycle.- 2 Natural family planning and hormonal assays in Japan.- 3 Billings natural FP method: correlation of subjective signs with ovulation and cervical mucus quality.- 4 Clinical evaluation of endocrine profile by BBT records in dysovulatory infertility.- 5 Fast procedures for serum LH with commercial reagents.- 6 The optimization of an immunochemical test to locate the fertile period in women.- 7 The dual analyte assay for the detection of the fertile period in women.- 8 The relationship between the ratio of E1 3-G/Pd-3-G and the fertile period.- 9 Prolactin, gonadotrophins and oestrogen levels in lactating puerperae and in non-lactating puerperae treated with metergoline or bromocriptine.- 10 PGE2 versus methyl-ergometrin in the puerperium. Influence in uterine involution and on lactation patterns.- Section 2: Steroid Contraception.- 11 Comparative randomized double-blind study of high dosage ethinyloestradiol VS ethinyloestradiol-norgenstrel combination in postcoital hormonal contraception.- 12 The contraceptive effect of the pill is not mediated by the quality of the peritoneal fluid.- 13 Carbohydrate metabolism alterations under monophasic, sequential and triphasic oral contraceptives containing ethinyloestradiol plus levonorgestrel or desogestrel.- 14 Impact of oral contraceptives upon serum lipoprotein pattern in healthy women.- 15 Androgenic action of progestins used in oral contraceptives.- 16 Triquilar: a low-dose triphasic oral contraceptive.- 17 Possible protection from breast cancer with long-term oral contraceptive use.- 18 The effects of active immunization of marmoset monkeys against the beta subunit of ovine luteinizing hormone (oLH Beta).- Section 3: Vaginal and Intra-Uterine Contraception.- 19 Clinical and experimental evaluation of a new vaginal contraceptive.- 20 Benzalkonium chloride - a new vaginal contraceptive.- 21 Contraception at caesarean delivery.- 22 The combined Multiload Copper 250 Short IUD in women with reduced uterine cavity measurements.- 23 Observations on the ML Cu 375.- 24 Copper medicated IUDs are not associated with abortion.- 25 Early chorionic activity in IUD bearing women. Preliminary report.- 26 Cytological findings in women with different methods of fertility regulation including spermatozoal recovery rates.- 27 A bacteriological study of the endometrial cavity, after up to seven years use of butterfly IUD.- 28 The IUD: a decade review.- Section 4: Abortion and Sterilization.- 29 Study on the effect of LH-RH analog in the termination of pregnancy.- 30 Prophylactic metronidazole in first-trimester induced abortion - a clinical, controlled trial in high-risk women.- 31 Coagulation methods for tubai sterilization - proved in animal model.- 32 Pregnancy rates after laparoscopic tubal sterilization by means of mechanical and coagulating techniques.- 33 Acceptability of laparoscopic tubal ligation by fallope ring when available among other family planning methods in rural Egypt.- 34 Men's attitude in Israel towards sterilization by vasectomy.- Section 5: Social Aspects.- 35 Reproductive characteristics of Libyan women.- 36 Fertility regulation clinic in Libyan Arab Jamahiriya at Benghazi.- 37 A family planning survey in Ireland.- Section 6: The Male.- 38 Direct effect of gossypol on the metabolism of rat Leydig cells.- 39 Gossypol as a male oral contraceptive - trial case report.